Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer

$1.36M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Fred Hutchinson Cancer Center
Country	United States
Start Date	Apr 01, 2021
End Date	Mar 31, 2026
Duration	1,825 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10746367`

Grant Description

PROJECT SUMMARY/ABSTRACT Per the FOA, this section is not required. The research supplement proposal does not change the activities of the parent award.